Javascript must be enabled to continue!
Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide
View through CrossRef
Background: forgiveness is the ability of a given regimen to maintain complete viral suppression despite a documented imperfect adherence. We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide. Methods: drug refills were used to calculate the percent day covered (PDC) as a proxy of adherence. Forgiveness was calculated as the achieved rate of a selected HIV-RNA threshold by a given level of imperfect adherence. Results: 281 adult PLWH were followed for 343 patient/years. Adherence was very high with a median of 98% (IQR 95-100%). A PDC as low as 70% was sufficient to obtain 100% and maintain virologic suppression. According to probit analysis adherence was not related to the possibility to maintain an HIV-RNA TND or < 50 copies/ml. Conclusions: Long-term success of ART needs effective regimens that are the least intrusive of the patient's lifestyle, an elevated forgiveness may be considered as an additional feature that can further improve long-term outcomes.
Title: Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide
Description:
Background: forgiveness is the ability of a given regimen to maintain complete viral suppression despite a documented imperfect adherence.
We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide.
Methods: drug refills were used to calculate the percent day covered (PDC) as a proxy of adherence.
Forgiveness was calculated as the achieved rate of a selected HIV-RNA threshold by a given level of imperfect adherence.
Results: 281 adult PLWH were followed for 343 patient/years.
Adherence was very high with a median of 98% (IQR 95-100%).
A PDC as low as 70% was sufficient to obtain 100% and maintain virologic suppression.
According to probit analysis adherence was not related to the possibility to maintain an HIV-RNA TND or < 50 copies/ml.
Conclusions: Long-term success of ART needs effective regimens that are the least intrusive of the patient's lifestyle, an elevated forgiveness may be considered as an additional feature that can further improve long-term outcomes.
Related Results
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Background:
Tenofovir disoproxil fumarate is a prodrug of tenofovir diphosphate that
exposes patients to renal toxicity over the long term. Tenofovir alafenamide, a new prodrug, no...
The Older, the More Forgiving? Characteristics of Forgiveness of Chinese Older Adults
The Older, the More Forgiving? Characteristics of Forgiveness of Chinese Older Adults
This study explores the characteristics of forgiveness in the aging cohorts, which is regarded to be associated with healthy outcomes. Data were drawn from a sample of 308 older ad...
Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study
Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study
Abstract
Background
Crushing or dissolving bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC) tablets is not recommen...
Point-of-care semiquantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate
Point-of-care semiquantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate
Synopsis
Objective
Objective measurement of antiretrovirals may aid clinical interventions for improving adherence to HIV preve...
Forgiveness and mental Well-being: a transnational comparison
Forgiveness and mental Well-being: a transnational comparison
Purpose
The purpose of this study was to investigate forgiveness and mental well-being amongst Forgiveness and mental well-being were investigated amongst British European and Nige...
Forgiveness at Work, Forgiveness at Home? Testing the Context-Dependence of Forgiveness-Related Attitudes and Values
Forgiveness at Work, Forgiveness at Home? Testing the Context-Dependence of Forgiveness-Related Attitudes and Values
Research and theory on forgiveness in the workplace draws considerably on results from the study of close relationships. This paper considers whether forgiveness-related attitudes ...
Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis
Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis
ABSTRACTBackgroundHepatitis B virus (HBV) infection causes liver disease, including hepatocellular carcinoma. Controlling viral activity is crucial to reducing complications. Tenof...
Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz+lamivudine+tenofovir disoproxil among HIV-1 patients newly starting treatment in China
Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz+lamivudine+tenofovir disoproxil among HIV-1 patients newly starting treatment in China
Abstract
Background: Though bictegravir/emtricitabine/tenofovir (BIC/TAF/TAF) have been regulatory approved and included in the National Reimbursement Drug List in China, d...

